OR WAIT null SECS
July 02, 2012
Tracking changes from spinoffs of chemical companies to life-sciences powerhouses.
Companies roll out expansions in manufacturing high-potency APIs and finished products.
Sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.
Flow chemistry and microreactors offer alternatives to traditional batch manufacturing.
June 02, 2012
Peptides and related technologies to are starting to improve production.
Industry wants more innovation, but can suppliers meet customer needs?
Partnerships between industry and academic medical centers are expanding to meet R&D needs.
May 02, 2012
Targeted polymeric nanoparticles are an important vehicle for controlling and targeting dosing of chemotherapeutic agents.
Advances in palladium-catalyzed hydrogenation, visible-light photocatalysis, and chemocatalyisis for heterocycles are some recent developments.
Industry, the public sector, and individuals can play an important role in creating solutions.